title: [Hearing loss after erythromycin therapy].
abstract: We describe the case of a patient who developed bilateral loss of hearing during intravenous treatment with erythromycin. Predisposing factors may have been reduced renal and hepatic function and treatment with diuretics and aminoglycosides. Recovery was late, but hearing was probably restored to almost pre-treatment level. Patients receiving high doses of erythromycin should, as a routine, be questioned about hearing loss and tinnitus.
authors.affiliation: Ore-nese-halsavdelingen, Haukeland Sykehus, Bergen.
authors.forename: O
authors.initials: O
authors.lastname: Lind
authors.forename: S
authors.initials: S
authors.lastname: Harthug
mesh_terms: D001299:Audiometry; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects*; D006312:Hearing Loss, Bilateral / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous
chemical_list: D004917:Erythromycin
vernacular_title: Hørselstap etter erytromycinbehandling.